NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in ...
Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center , positioning the company for ...
Fast Track designation granted by U.S. FDA for evaluation of ETX-19477 in patients with BRCA-mutated, platinum-resistant ...
Major drugmakers are participating in a new FDA fast-track review program despite concerns about potential legal risks. The ...
Licenses Real-World Evidence From 70,000 Patients To Support FDA Accelerated Approval Of NRX-100. NRx Pharmaceuticals (NASDAQ: NRXP) announced it has licensed regulatory-grade real-world evidence ...
The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback